Varex Q3 FY26 revenue $211M, up 4% YoY; non-GAAP EPS $0.31 vs $0.13

Varex Imaging Corp

Revenue $211M, up 4% YoY; Medical $134M, Industrial $77M; non-GAAP EPS $0.31 vs $0.13 prior year.
Received $17M U.S. Customs refunds for IEEPA tariffs; recorded $7M revenue reduction for customer reimbursements, boosting gross profit ~$10M.
Non-GAAP gross margin improved to 37% from 34% YoY; operating cash flow $21M.
Cash and marketable securities $99M vs $155M at FY25 end, reflecting March debt redemption/refinancing and inventory working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.